TESARO, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-03-01
- Employees
- 715
- Market Cap
- -
- Website
- http://tesarobio.com
A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Tesaro, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01110603
A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- Tesaro, Inc.
- Target Recruit Count
- 113
- Registration Number
- NCT00749502
© Copyright 2024. All Rights Reserved by MedPath